Nektar Therapeutics (NKTR) quarterly cash flow statement — complete operating, investing & financing history
Nektar Therapeutics (NKTR) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -75.77M | -44.3M | -64.96M | -48.76M | -45.74M | -49.05M | -46.19M | -43.93M | -37.7M | -47.89M | -47.05M | -42.12M | -51.52M | -51.91M | -57.7M | -82.89M | -74.99M | -88.42M | -151.54M | -101.14M |
| Operating CF Margin % | -747.9% | -407.86% | -297.88% | -413.58% | -409.29% | -468.96% | -158.31% | -182.11% | -160.51% | -221.3% | -196.97% | -174.46% | -251.34% | -240.41% | -262.01% | -350.84% | -347.43% | -356.23% | -605.93% | -405.83% |
| Operating CF Growth % | -65.66% | 9.69% | -40.64% | -10.99% | -21.31% | -2.43% | 1.83% | -4.3% | 26.82% | 7.76% | 18.47% | 49.18% | 31.3% | 41.29% | 61.92% | 18.04% | 9.54% | -14.71% | -53.64% | -92% |
| Net Income | -40.62M | -44.9M | -36.08M | -35.52M | -41.59M | -50.88M | 7.26M | -37.06M | -52.36M | -36.8M | -42.08M | -45.84M | -51.12M | -137.02M | -59.69M | -59.05M | -159.07M | -90.39M | -145.65M | -129.71M |
| Depreciation & Amortization | 156K | 151K | -374K | 196K | -655K | 426K | 332K | 993K | 1.46M | 1.61M | 1.65M | 1.7M | 2.17M | 2.3M | 2.35M | 2.68M | 3.44M | 3.73M | 2.29M | 3.62M |
| Stock-Based Compensation | 3.37M | 3.35M | 2.19M | 3.07M | 3.49M | 3.9M | 4.8M | 5.39M | 5.42M | 0 | 7.25M | 8.15M | 0 | 10.02M | 0 | 12.52M | 11.1M | 20.96M | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -31K | 57K | -38K | 1.71M | -15K | -27K | -1.81M | 2.71M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 7.95M | -2.83M | -7.58M | -6.34M | -3.4M | -2.35M | -47.07M | -14.29M | -3.08M | -6.03M | -10.86M | -2.88M | 6.52M | 77.07M | 4.99M | -11.26M | 47.71M | -37.23M | 43.65M | 28.66M |
| Working Capital Changes | -46.61M | -68K | -23.12M | -10.16M | -3.58M | -146K | -11.52M | 1.06M | 10.8M | -6.62M | -4.73M | -3.23M | -9.06M | -2.47M | -8.07M | -27.77M | 21.82M | 14.51M | -51.83M | -3.71M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | -2.2M | -850K | 2.42M | -2.41M | 999K | -869K | 1.66M | 2.99M | 5.55M | -1.53M | 20.21M | -7.73M | 2.5M | -123K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 1.3M | 123K | 212K | -1.14M | 1.07M | 2.37M | -454K | -1.99M | -145K | -2.09M | -1.59M | 422K | -471K | -714K |
| Change in Payables | 15.05M | -934K | -4.79M | 1.28M | -3.52M | 6.41M | 3.69M | 2.24M | -2.28M | -988K | 6.44M | 669K | -1.08M | -8.92M | 7.29M | -7.02M | -165K | 3M | -12.94M | 3.35M |
| Cash from Investing | -399.11M | -350.79M | 372K | -94.87M | 49.62M | 43.69M | 60.21M | 46.12M | 16.98M | 19.26M | 17.38M | 56.41M | 25.17M | 40.6M | 40.01M | 111.39M | 84.15M | 130.28M | 120.2M | -830K |
| Capital Expenditures | -112K | -18K | -18K | -114K | -37K | -2K | -459K | -666K | -186K | -157K | -237K | -33K | -162K | -433K | -512K | -181K | -780K | -4.2M | -5.9M | -2.94M |
| CapEx % of Revenue | 1.11% | 0.17% | 0.08% | 0.97% | 0.33% | 0.02% | 1.57% | 2.76% | 0.79% | 0.73% | 0.99% | 0.14% | 0.79% | 2.01% | 2.32% | 0.77% | 3.61% | 16.93% | 23.58% | 11.78% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.2M | -111.58M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 18K | 0 | 0 | 0 | 0 | -697K | 65.39M | 0 | 0 | 0 | 0 | 1.25M | 0 | 0 | 0 | 111.58M | 0 | 0 | 0 | 0 |
| Cash from Financing | 364.57M | 529.55M | 38.67M | 141.68M | 211K | 7K | 83K | 13K | 19K | 42M | 12K | 0 | 18K | 0 | 103K | 0 | 467K | 938K | 2.55M | 3.66M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 365.35M | 529.55M | 38.67M | 141.68M | 211K | 7K | 83K | 13K | 19K | 27M | 12K | 0 | 18K | 0 | 103K | 0 | 467K | 0 | 1.8M | 2.91M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -784K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 938K | 750K | 750K |
| Net Change in Cash | -110.31M | 128.67M | -1.2M | -1.96M | 4.09M | -5.36M | 14.14M | 2.14M | -20.82M | 14.58M | -29.57M | 14.19M | -26.23M | -11.27M | -23.18M | 28.21M | 10.93M | 42.77M | -39.74M | 39.96M |
| Free Cash Flow | -75.88M | -44.32M | -64.98M | -48.88M | -45.77M | -49.05M | -46.65M | -44.6M | -37.89M | -48.05M | -47.28M | -42.15M | -51.69M | -52.35M | -58.22M | -83.07M | -75.77M | -92.63M | -157.43M | -104.07M |
| FCF Margin % | -749.01% | -408.03% | -297.96% | -414.55% | -409.62% | -468.98% | -159.88% | -184.87% | -161.3% | -222.03% | -197.97% | -174.59% | -252.13% | -242.42% | -264.34% | -351.61% | -351.04% | -373.16% | -629.51% | -417.61% |
| FCF Growth % | -65.77% | 9.66% | -39.3% | -9.59% | -20.82% | -2.1% | 1.35% | -5.8% | 26.69% | 8.22% | 18.78% | 49.25% | 31.79% | 43.49% | 63.02% | 20.18% | 12.08% | -15.84% | -56.83% | -90.66% |
| FCF per Share | -2.30 | -1.79 | -3.20 | -3.47 | -3.25 | -3.49 | -3.28 | -3.20 | -2.72 | -3.70 | -3.71 | -3.32 | -4.09 | -4.16 | -4.64 | -6.64 | -6.08 | -7.48 | -12.77 | -8.48 |
| FCF Conversion (FCF/Net Income) | 1.87x | 0.99x | 1.80x | 1.37x | 1.10x | 0.96x | -6.36x | 1.19x | 0.72x | 1.30x | 1.12x | 0.92x | 1.01x | 0.38x | 0.97x | 1.40x | 0.47x | 0.98x | 1.04x | 0.78x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -85K | 0 | 0 | 0 | 0 |